nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—Pseudomembranous enterocolitis—Riluzole—amyotrophic lateral sclerosis	0.312	0.332	CcSEcCtD
Sulfamethoxazole—Methaemoglobinaemia—Riluzole—amyotrophic lateral sclerosis	0.0508	0.0541	CcSEcCtD
Sulfamethoxazole—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.0319	0.0339	CcSEcCtD
Sulfamethoxazole—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.03	0.0319	CcSEcCtD
Sulfamethoxazole—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0209	0.0222	CcSEcCtD
Sulfamethoxazole—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.0207	0.022	CcSEcCtD
Sulfamethoxazole—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.02	0.0213	CcSEcCtD
Sulfamethoxazole—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0172	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.014	0.0149	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0131	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0129	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0122	CcSEcCtD
Sulfamethoxazole—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0113	0.012	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0116	CcSEcCtD
Sulfamethoxazole—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0108	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00919	0.00978	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0089	0.00947	CcSEcCtD
Sulfamethoxazole—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00877	0.00932	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00856	0.0091	CcSEcCtD
Sulfamethoxazole—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00841	0.00894	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00836	0.00889	CcSEcCtD
Sulfamethoxazole—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00836	0.00889	CcSEcCtD
Sulfamethoxazole—Depression—Riluzole—amyotrophic lateral sclerosis	0.00834	0.00886	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00819	0.00871	CcSEcCtD
Sulfamethoxazole—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00815	0.00867	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00791	0.00841	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0078	0.0083	CcSEcCtD
Sulfamethoxazole—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0075	0.00798	CcSEcCtD
Sulfamethoxazole—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00747	0.00794	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00741	0.00788	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00737	0.00784	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00736	0.00782	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0071	0.00755	CcSEcCtD
Sulfamethoxazole—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00746	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00678	0.00721	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00676	0.00719	CcSEcCtD
Sulfamethoxazole—Chills—Riluzole—amyotrophic lateral sclerosis	0.00673	0.00716	CcSEcCtD
Sulfamethoxazole—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00657	0.00699	CcSEcCtD
Sulfamethoxazole—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00653	0.00695	CcSEcCtD
Sulfamethoxazole—Tension—Riluzole—amyotrophic lateral sclerosis	0.00641	0.00682	CcSEcCtD
Sulfamethoxazole—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00634	0.00675	CcSEcCtD
Sulfamethoxazole—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00597	0.00635	CcSEcCtD
Sulfamethoxazole—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00587	0.00624	CcSEcCtD
Sulfamethoxazole—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00585	0.00622	CcSEcCtD
Sulfamethoxazole—Cough—Riluzole—amyotrophic lateral sclerosis	0.0057	0.00606	CcSEcCtD
Sulfamethoxazole—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00566	0.00602	CcSEcCtD
Sulfamethoxazole—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00591	CcSEcCtD
Sulfamethoxazole—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00591	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00552	0.00587	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00567	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00556	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00555	CcSEcCtD
Sulfamethoxazole—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00518	0.00551	CcSEcCtD
Sulfamethoxazole—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00508	0.0054	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00517	CcSEcCtD
Sulfamethoxazole—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00482	0.00513	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00506	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00499	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00493	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0046	0.0049	CcSEcCtD
Sulfamethoxazole—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0046	0.00489	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00464	CcSEcCtD
Sulfamethoxazole—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00424	0.0045	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00448	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00448	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00418	CcSEcCtD
Sulfamethoxazole—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00407	CcSEcCtD
Sulfamethoxazole—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00401	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00388	CcSEcCtD
Sulfamethoxazole—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00375	CcSEcCtD
Sulfamethoxazole—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00361	CcSEcCtD
Sulfamethoxazole—Rash—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00358	CcSEcCtD
Sulfamethoxazole—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00357	CcSEcCtD
Sulfamethoxazole—Headache—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00355	CcSEcCtD
Sulfamethoxazole—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00337	CcSEcCtD
Sulfamethoxazole—NAT1—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00295	0.0494	CbGpPWpGaD
Sulfamethoxazole—NAT1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00173	0.0289	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.0017	0.0285	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.0016	0.0268	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00138	0.0232	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00132	0.0221	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00132	0.0221	CbGpPWpGaD
Sulfamethoxazole—NAT2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00123	0.0205	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00121	0.0202	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00112	0.0188	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00106	0.0177	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000956	0.016	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00092	0.0154	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000788	0.0132	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—amyotrophic lateral sclerosis	0.000784	0.0131	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000756	0.0126	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000725	0.0121	CbGpPWpGaD
Sulfamethoxazole—NAT2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000717	0.012	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000707	0.0118	CbGpPWpGaD
Sulfamethoxazole—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.000695	0.0116	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000669	0.0112	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000644	0.0108	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	0.000614	0.0103	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000607	0.0102	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.000567	0.00949	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000557	0.00933	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000549	0.00919	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000549	0.00919	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000549	0.00919	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00054	0.00904	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.000511	0.00854	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.000509	0.00852	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000506	0.00846	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000502	0.00841	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000502	0.0084	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.000486	0.00814	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000472	0.00789	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000467	0.00781	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000439	0.00735	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000429	0.00718	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000426	0.00713	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000426	0.00713	CbGpPWpGaD
Sulfamethoxazole—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000399	0.00668	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000397	0.00664	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000393	0.00657	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000365	0.00611	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000364	0.00608	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000356	0.00596	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000354	0.00592	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00035	0.00585	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000343	0.00574	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000324	0.00543	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00032	0.00535	CbGpPWpGaD
Sulfamethoxazole—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000311	0.0052	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000301	0.00504	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000298	0.00498	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000295	0.00494	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000294	0.00491	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000288	0.00482	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000284	0.00476	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000283	0.00474	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00028	0.00468	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000278	0.00465	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000271	0.00454	CbGpPWpGaD
Sulfamethoxazole—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000265	0.00444	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000264	0.00442	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000261	0.00437	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000252	0.00421	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000249	0.00417	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000247	0.00413	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000246	0.00412	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000239	0.004	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000235	0.00393	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000235	0.00393	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000229	0.00383	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000228	0.00382	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000226	0.00379	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000226	0.00378	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000225	0.00376	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000223	0.00373	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000207	0.00346	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000206	0.00344	CbGpPWpGaD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000205	0.00344	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000203	0.0034	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000192	0.00322	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000192	0.00321	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000191	0.0032	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000191	0.0032	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000191	0.0032	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000187	0.00313	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000184	0.00308	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000183	0.00306	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000181	0.00302	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.00018	0.00301	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00018	0.00301	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000178	0.00298	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000175	0.00292	CbGpPWpGaD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000175	0.00292	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000168	0.00281	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000163	0.00272	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000162	0.00271	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000158	0.00264	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000156	0.00262	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000156	0.00261	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000156	0.00261	CbGpPWpGaD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000156	0.0026	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000153	0.00256	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000153	0.00256	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000151	0.00252	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000149	0.00249	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000147	0.00246	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000145	0.00243	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000143	0.0024	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000143	0.00238	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000138	0.00231	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000132	0.00222	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000131	0.0022	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00013	0.00217	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00013	0.00217	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000125	0.00208	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000124	0.00207	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000123	0.00206	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000123	0.00205	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000121	0.00202	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000117	0.00195	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000116	0.00194	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000113	0.00188	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000113	0.00188	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000109	0.00183	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000107	0.00179	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000105	0.00176	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000105	0.00175	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000104	0.00175	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000101	0.00169	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000101	0.00168	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000101	0.00168	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0001	0.00167	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0001	0.00167	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	9.83e-05	0.00165	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	9.82e-05	0.00164	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSR—amyotrophic lateral sclerosis	9.67e-05	0.00162	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.38e-05	0.00157	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	9.37e-05	0.00157	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.33e-05	0.00156	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—APOE—amyotrophic lateral sclerosis	9.27e-05	0.00155	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	9.21e-05	0.00154	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	9.15e-05	0.00153	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.87e-05	0.00148	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.87e-05	0.00148	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.8e-05	0.00147	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	8.67e-05	0.00145	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.56e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.54e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.51e-05	0.00142	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	8.19e-05	0.00137	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	8.19e-05	0.00137	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	8.05e-05	0.00135	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	8e-05	0.00134	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CHAT—amyotrophic lateral sclerosis	7.94e-05	0.00133	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.91e-05	0.00132	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	7.88e-05	0.00132	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.64e-05	0.00128	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	7.49e-05	0.00125	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	7.28e-05	0.00122	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.24e-05	0.00121	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	7.24e-05	0.00121	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.18e-05	0.0012	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.05e-05	0.00118	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.97e-05	0.00117	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.95e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	6.68e-05	0.00112	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	6.55e-05	0.0011	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.47e-05	0.00108	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.35e-05	0.00106	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	5.92e-05	0.000991	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.9e-05	0.000988	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	5.64e-05	0.000944	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	5.51e-05	0.000923	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	5.48e-05	0.000917	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	5.4e-05	0.000904	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	5.4e-05	0.000904	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	5.09e-05	0.000852	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	5.06e-05	0.000847	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	5.06e-05	0.000847	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.96e-05	0.00083	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	4.94e-05	0.000827	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.64e-05	0.000775	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.61e-05	0.000771	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.59e-05	0.000769	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	4.49e-05	0.000751	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	4.36e-05	0.00073	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.32e-05	0.000723	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.27e-05	0.000714	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	4.18e-05	0.000699	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	4.16e-05	0.000695	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	4.14e-05	0.000693	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.05e-05	0.000677	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.92e-05	0.000656	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.91e-05	0.000653	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.81e-05	0.000638	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.79e-05	0.000634	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.77e-05	0.000631	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.48e-05	0.000582	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.44e-05	0.000576	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	3.4e-05	0.000569	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOE—amyotrophic lateral sclerosis	3.23e-05	0.00054	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.2e-05	0.000535	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.1e-05	0.000519	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.96e-05	0.000495	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.73e-05	0.000457	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	2.63e-05	0.00044	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.61e-05	0.000437	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.6e-05	0.000435	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.25e-05	0.000376	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.25e-05	0.000376	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.24e-05	0.000375	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.23e-05	0.000374	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.21e-05	0.00037	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.13e-05	0.000356	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.06e-05	0.000345	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.05e-05	0.000343	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.83e-05	0.000306	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.8e-05	0.000301	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.7e-05	0.000284	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.7e-05	0.000284	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.69e-05	0.000283	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.68e-05	0.000281	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.38e-05	0.000231	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.21e-05	0.000202	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.16e-05	0.000195	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.16e-05	0.000194	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.11e-05	0.000185	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.47e-06	0.000158	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	9.12e-06	0.000153	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.25e-06	0.000105	CbGpPWpGaD
